A controlled trial of androgen therapy in experimental chronic hypoplastic marrow failure.
A controlled trial of an androgen, 17-nortestosterone decanoate, was carried out to test its effect as therapy in an experimental model of chronic hypoplastic marrow failure. No effect was detected.